Storage guidance: Store at controlled room temperature
S. Seiwerthet al., Stable Gastric Pentadecapeptide BPC 157 and Wound Healing, Frontiers Media SA, Jun. 2021. doi: 10.3389/fphar.2021.627533
Summary: Cagrilintide and retatrutide are investigational injectable medicines being studied for obesity and type 2 diabetes in men, targeting multiple hormonal pathways to reduce appetite, improve blood glucose control, and increase energy expenditure, but neither is currently licensed in the UK
While most are mild , practitioners should be aware of both common and rare reactions: Common : mild soreness at the injection site, flushing, or temporary nausea
Third-party HPLC-MS verified 99% purity
Here at Real Peptides, our work is grounded in the precision of biochemistry, and understanding these interactions is absolutely critical for valid, repeatable research